OptimizeRx (OPRX) SEC Filings & 10K Form

$9.09
-0.23 (-2.47%)
(As of 04/22/2024 ET)

Recent OptimizeRx SEC Filings

DateFilerForm TypeView
04/22/2024
7:37 AM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
04/22/2024
7:31 AM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
04/18/2024
3:30 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
4:22 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:41 PM
OptimizeRx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:15 AM
OptimizeRx (Filer)
Form NT 10-K
03/06/2024
3:19 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:22 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:23 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:24 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:25 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:16 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:53 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:04 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/26/2024
3:00 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
4:56 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:06 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:28 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
4:19 PM
OptimizeRx (Filer)
Form 8-K/A
12/29/2023
4:30 PM
Divisadero Street Capital Management, LP (Filed by)
OptimizeRx (Subject)
Form SC 13G
11/13/2023
1:32 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
6:15 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
9:49 AM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
3:06 PM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2023
3:31 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
1:18 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
9:03 AM
HALAS GUS D (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
8:28 AM
OptimizeRx (Issuer)
WASSON GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
8:29 AM
OptimizeRx (Issuer)
Vos Ellen O'Connor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
8:31 AM
Lang James Paul (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
8:33 AM
OptimizeRx (Issuer)
Spangler Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
3:31 PM
OptimizeRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/09/2023
3:31 PM
First Light Asset Management, LLC (Filed by)
OptimizeRx (Subject)
Form SC 13G
04/25/2023
3:28 PM
OptimizeRx (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:OPRX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners